Xiaoning Lin
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in ⓘ
- Genetics 4
- Glioma Diagnosis and Treatment 4
- Virus-based gene therapy research 3
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Huang (1 shared paper)Diao (1 shared paper)Ren Ren (1 shared paper)Wei Nie (1 shared paper)Xinhua Tian (9 shared papers)Lei Ren (4 shared papers)Yanlin Huang (5 shared papers)Jin Sun (4 shared papers)
- Journals
- International Journal of Nanomedicine (5 papers)Annals of Palliative Medicine (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Human Cell (1 paper)Small Methods (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaoning Lin
26 papers receiving 707 citations
Peers
Comparison fields: 5 of 87
- Biomaterials 187
- Pharmaceutical Science 80
- Cancer Research 157
- Developmental Neuroscience 30
- Molecular Biology 357
Countries citing papers authored by Xiaoning Lin
This map shows the geographic impact of Xiaoning Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoning Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoning Lin more than expected).
Fields of papers citing papers by Xiaoning Lin
This network shows the impact of papers produced by Xiaoning Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoning Lin. The network helps show where Xiaoning Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoning Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 161 | |
| 2 | 2015 | 137 | |
| 3 | 2017 | 73 | |
| 4 | 2012 | 57 | |
| 5 | 2022 | 56 | |
| 6 | 2021 | 52 | |
| 7 | 2013 | 36 | |
| 8 | Passive Smoking and Other Factors at Different Periods of Life and Breast Cancer Risk in Chinese Women who have Never Smoked - A Case-control Study in Chongqing, People's Republic of China. | 2000 | 29 |
| 9 | 2011 | 24 | |
| 10 | 2020 | 24 | |
| 11 | 2023 | 16 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 8 | |
| 14 | 2017 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2010 | 3 | |
| 19 | 2020 | 2 | |
| 20 | [Research on Tat peptide-polyethylene glycol modified gelatin-siloxane nanoparticles across the blood-brain barrier]. | 2012 | 2 |
About Xiaoning Lin
Xiaoning Lin is a scholar working on Genetics, Biomaterials, Developmental Neuroscience, Biotechnology and Molecular Biology, having authored 27 papers that have together received 713 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Glioma Diagnosis and Treatment (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Virus-based gene therapy research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Meningioma and schwannoma management (3 papers), MicroRNA in disease regulation (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Biomaterials (187 citations), Pharmaceutical Science (80 citations), Cancer Research (157 citations), Developmental Neuroscience (30 citations) and Molecular Biology (357 citations). Xiaoning Lin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Huang, Diao, Ren Ren, Wei Nie, Xinhua Tian, Lei Ren, Yanlin Huang, Jin Sun, Luyue Chen and Huiling Shen. Their work appears in journals such as International Journal of Nanomedicine, Annals of Palliative Medicine, Frontiers in Cell and Developmental Biology, Human Cell and Small Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.